OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Empagliflozin Preserves Skeletal Muscle Function in a HFpEF Rat Model
Ephraim B. Winzer, Antje Schauer, Erik Langner, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 10989-10989
Open Access | Times Cited: 22
Ephraim B. Winzer, Antje Schauer, Erik Langner, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 10989-10989
Open Access | Times Cited: 22
Showing 22 citing articles:
Diet, exercise, and pharmacotherapy for sarcopenia in people with diabetes
Yoshitaka Hashimoto, Fuyuko Takahashi, Takuro Okamura, et al.
Metabolism (2023) Vol. 144, pp. 155585-155585
Closed Access | Times Cited: 46
Yoshitaka Hashimoto, Fuyuko Takahashi, Takuro Okamura, et al.
Metabolism (2023) Vol. 144, pp. 155585-155585
Closed Access | Times Cited: 46
Impaired skeletal muscle regeneration in diabetes: From cellular and molecular mechanisms to novel treatments
Ever Espino‐Gonzalez, Emilie Dalbram, Rémi Mounier, et al.
Cell Metabolism (2024) Vol. 36, Iss. 6, pp. 1204-1236
Open Access | Times Cited: 24
Ever Espino‐Gonzalez, Emilie Dalbram, Rémi Mounier, et al.
Cell Metabolism (2024) Vol. 36, Iss. 6, pp. 1204-1236
Open Access | Times Cited: 24
Sodium–glucose cotransporter 2 inhibitors influence skeletal muscle pathology in patients with heart failure and reduced ejection fraction
Nathanael Wood, Sam Straw, Chew W. Cheng, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 4, pp. 925-935
Open Access | Times Cited: 10
Nathanael Wood, Sam Straw, Chew W. Cheng, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 4, pp. 925-935
Open Access | Times Cited: 10
Empagliflozin Improves Diastolic Function in HFpEF by Restabilizing the Mitochondrial Respiratory Chain
Antje Schauer, Volker Adams, Susanne Kämmerer, et al.
Circulation Heart Failure (2024) Vol. 17, Iss. 6
Open Access | Times Cited: 8
Antje Schauer, Volker Adams, Susanne Kämmerer, et al.
Circulation Heart Failure (2024) Vol. 17, Iss. 6
Open Access | Times Cited: 8
Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction in Preclinical Nondiabetic Chronic Kidney Disease
Ixchel Lima‐Posada, Matthieu Soulié, Yohan Stephan, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 12
Open Access | Times Cited: 4
Ixchel Lima‐Posada, Matthieu Soulié, Yohan Stephan, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 12
Open Access | Times Cited: 4
Effects of antidiabetic agents on lipid metabolism of skeletal muscle: A narrative review
Ming Xu, Dongqing Lv, Hongxia Wei, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Ming Xu, Dongqing Lv, Hongxia Wei, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
SGLT2 inhibitor dapagliflozin mitigates skeletal muscle pathology by modulating key proteins involved in glucose and ion homeostasis in an animal model of heart failure
Elena Conte, Paola Imbrici, Giorgia Dinoi, et al.
European Journal of Pharmacology (2025), pp. 177617-177617
Open Access
Elena Conte, Paola Imbrici, Giorgia Dinoi, et al.
European Journal of Pharmacology (2025), pp. 177617-177617
Open Access
Hepatoprotective and cardioprotective effects of empagliflozin in spontaneously hypertensive rats fed a high-fat diet
Silvie Hojná, Hana Malínská, Martina Hüttl, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116520-116520
Open Access | Times Cited: 3
Silvie Hojná, Hana Malínská, Martina Hüttl, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116520-116520
Open Access | Times Cited: 3
Caloric Restriction Rejuvenates Skeletal Muscle Growth in Heart Failure With Preserved Ejection Fraction
Ever Espino‐Gonzalez, Peter G. Tickle, Raffaele Altara, et al.
JACC Basic to Translational Science (2023) Vol. 9, Iss. 2, pp. 223-240
Open Access | Times Cited: 9
Ever Espino‐Gonzalez, Peter G. Tickle, Raffaele Altara, et al.
JACC Basic to Translational Science (2023) Vol. 9, Iss. 2, pp. 223-240
Open Access | Times Cited: 9
Effects of dapagliflozin monotherapy and combined aerobic exercise on skeletal muscle mitochondrial quality control and insulin resistance in type 2 diabetes mellitus rats
Liangzhi Zhang, Hengjun Lin, Xudong Yang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115852-115852
Open Access | Times Cited: 8
Liangzhi Zhang, Hengjun Lin, Xudong Yang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115852-115852
Open Access | Times Cited: 8
Leucine Supplementation Prevents the Development of Skeletal Muscle Dysfunction in a Rat Model of HFpEF
Paula Ketilly Nascimento Alves, Antje Schauer, Antje Augstein, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 502-502
Open Access | Times Cited: 3
Paula Ketilly Nascimento Alves, Antje Schauer, Antje Augstein, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 502-502
Open Access | Times Cited: 3
Diabetes Pharmacotherapy and its effects on the Skeletal Muscle Energy Metabolism
Baowen Yu, Dong Wang, Junming Zhou, et al.
Mini-Reviews in Medicinal Chemistry (2024) Vol. 24, Iss. 16, pp. 1470-1480
Closed Access | Times Cited: 2
Baowen Yu, Dong Wang, Junming Zhou, et al.
Mini-Reviews in Medicinal Chemistry (2024) Vol. 24, Iss. 16, pp. 1470-1480
Closed Access | Times Cited: 2
Adjunctive therapy with an oral H2S donor provides additional therapeutic benefit beyond SGLT2 inhibition in cardiometabolic heart failure with preserved ejection fraction
Jake E. Doiron, Huijing Xia, Xiaoman Yu, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 21, pp. 4294-4310
Open Access | Times Cited: 2
Jake E. Doiron, Huijing Xia, Xiaoman Yu, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 21, pp. 4294-4310
Open Access | Times Cited: 2
Therapeutic effects on the development of heart failure with preserved ejection fraction by the sodium-glucose cotransporter 2 inhibitor dapagliflozin in type 2 diabetes
Bin Feng, Peiran Yu, Hao Yu, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Bin Feng, Peiran Yu, Hao Yu, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Benefit of combination therapy with dapagliflozin and eplerenone on cardiac function and fibrosis in rats with non-diabetic chronic kidney disease
Matthieu Soulié, Yannick Stéphan, Manon Durand, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Matthieu Soulié, Yannick Stéphan, Manon Durand, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Locomotor and respiratory muscle abnormalities in HFrEF and HFpEF
Norman Mangner, Ephraim B. Winzer, Axel Linke, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 3
Norman Mangner, Ephraim B. Winzer, Axel Linke, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 3
Leucine Supplementation Improves Diastolic Function in HFpEF by HDAC4 Inhibition
Paula Ketilly Nascimento Alves, Antje Schauer, Antje Augstein, et al.
Cells (2023) Vol. 12, Iss. 21, pp. 2561-2561
Open Access | Times Cited: 3
Paula Ketilly Nascimento Alves, Antje Schauer, Antje Augstein, et al.
Cells (2023) Vol. 12, Iss. 21, pp. 2561-2561
Open Access | Times Cited: 3
Lean ZSF1 rats in basic research on heart failure with preserved ejection fraction
Petra Büttner, Antje Augstein, Mahmoud Abdellatif, et al.
ESC Heart Failure (2024)
Open Access
Petra Büttner, Antje Augstein, Mahmoud Abdellatif, et al.
ESC Heart Failure (2024)
Open Access
Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Body Composition and Fluid Status in Cardiovascular Rehabilitation Patients with Coronary Artery Disease and Heart Failure
José C. De La Flor, B Coto Morales, Elena Basabe, et al.
Medicina (2024) Vol. 60, Iss. 12, pp. 2096-2096
Open Access
José C. De La Flor, B Coto Morales, Elena Basabe, et al.
Medicina (2024) Vol. 60, Iss. 12, pp. 2096-2096
Open Access
Muscle Atrophy: From Bench to Bedside
Daniel Taillandier
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7551-7551
Open Access | Times Cited: 1
Daniel Taillandier
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7551-7551
Open Access | Times Cited: 1
Glucagon-Like Peptide-1 Receptor Agonists and Sodium Glucose Cotransporter-2 Inhibitors and Cardiorespiratory Fitness Interaction
David Ni, Peter Kokkinos, Eric Nylén
Military Medicine (2024)
Closed Access
David Ni, Peter Kokkinos, Eric Nylén
Military Medicine (2024)
Closed Access
Modulation of Titin and Contraction-Regulating Proteins in a Rat Model of Heart Failure with Preserved Ejection Fraction: Limb vs. Diaphragmatic Muscle
Beatrice Vahle, L. Heilmann, Antje Schauer, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6618-6618
Open Access
Beatrice Vahle, L. Heilmann, Antje Schauer, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6618-6618
Open Access
